This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyParametersWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
Lys Therapeutics strengthens its Board of Directors with the appointment of two internationally renowned experts in clinical development and strategic financing
Press ReleasesLys Therapeutics secures an additional €2.15 million in funding as a winner of the i-Nov innovation competition organized by the French government to accelerate the clinical development of its drug candidate LYS241
Press ReleasesLys Therapeutics Announces Significant Scientific Advances in Neurodegenerative and Neurovascular Diseases
Press ReleasesLys Therapeutics announces that Michel Vounatsos is appointed chairman of its Board of Directors
Press ReleasesLys Therapeutics announces €2 million grant from Bpifrance
Press ReleasesLys Therapeutics announces positive preclinical results for its drug candidate in synergy with gold standard treatments for ischemic stroke
Press ReleasesLys Therapeutics presents new preclinical data in Parkinson’s at the « International Congress of Parkinson’s Disease and Movement Disorders® »
Press ReleasesLys Therapeutics secures funding from The Michael J. Fox Foundation to accelerate the development of its drug candidate in Parkinson’s disease
Press ReleasesLys Therapeutics announces a seed round of 5.5 million euros to prepare future clinical studies for its first-in-class monoclonal antibody targeting neurovascular and neurodegenerative disorders
Press ReleasesNine startups are working on brain pathologies together with the Blood and Brain Institute BB@C in Normandy
Press ReleasesLys Therapeutics and Inserm Transfert sign a three-year agreement for joint research on stroke and multiple sclerosis
Press ReleasesLys Therapeutics and the BB@C Institute to hold a scientific conference in support of World Stroke Day
Press ReleasesLys Therapeutics, Grand Prize winner of the i-Lab innovation competition, accelerates its research on its lead drug-candidate Glunozumab
Press Releases